22 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34364883 | IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation. | 2022 Jan | 1 |
2 | 35273606 | C10orf99/GPR15L Regulates Proinflammatory Response of Keratinocytes and Barrier Formation of the Skin. | 2022 | 1 |
3 | 34016718 | Suppressor of cytokine signalling 3 (SOCS3) expressed in podocytes attenuates glomerulonephritis and suppresses autoantibody production in an imiquimod-induced lupus model. | 2021 May | 1 |
4 | 34153674 | Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation. | 2021 Sep | 1 |
5 | 34171426 | Co-delivery of methotrexate and nicotinamide by cerosomes for topical psoriasis treatment with enhanced efficacy. | 2021 Aug 10 | 1 |
6 | 34215755 | The RNase MCPIP3 promotes skin inflammation by orchestrating myeloid cytokine response. | 2021 Jul 2 | 1 |
7 | 34281197 | Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice. | 2021 Jul 1 | 2 |
8 | 34884834 | The Extracellular Vesicles from the Commensal Staphylococcus Epidermidis ATCC12228 Strain Regulate Skin Inflammation in the Imiquimod-Induced Psoriasis Murine Model. | 2021 Dec 2 | 1 |
9 | 32355189 | Keratinocyte transglutaminase 2 promotes CCR6+ γδT-cell recruitment by upregulating CCL20 in psoriatic inflammation. | 2020 Apr 30 | 1 |
10 | 32512223 | Percutaneous absorption of resveratrol and its oligomers to relieve psoriasiform lesions: In silico, in vitro and in vivo evaluations. | 2020 Jul 30 | 1 |
11 | 32556081 | Curcumin against imiquimod-induced psoriasis of mice through IL-6/STAT3 signaling pathway. | 2020 Jun 18 | 1 |
12 | 33060784 | Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6. | 2020 Oct 15 | 1 |
13 | 33081840 | Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. | 2020 Oct 20 | 1 |
14 | 33643287 | Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes. | 2020 | 1 |
15 | 30593001 | Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis. | 2019 Mar | 1 |
16 | 31659208 | Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis. | 2019 Oct 28 | 1 |
17 | 30564235 | Macrophage MMP10 Regulates TLR7-Mediated Tolerance. | 2018 | 2 |
18 | 26784569 | Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. | 2016 Mar | 1 |
19 | 27829595 | Imiquimod-induced CCR9 Ameliorates murine TNBS Colitis. | 2016 Dec 16 | 1 |
20 | 24387343 | Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod. | 2014 Feb | 1 |
21 | 22951726 | An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. | 2013 Feb | 1 |
22 | 23825622 | Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. | 2013 | 1 |